Ebselen inhibited H3N2 influenza virus-induced apoptosis through the mitochondria-mediated signaling pathway.

Publication date: Jun 24, 2025

After the waning impact of the new coronaviruses, influenza viruses have become prevalent again in the last two years. H3N2 is a subtype of the influenza A virus and has become the dominant and most watched strain of seasonal influenza in the past decade. Ebselen, an organic selenium compound, plays a role in cardiovascular health and cancer prevention due to its antimicrobial and antioxidant effects. In our latest study, ebselen was found to effectively inhibit H3N2-mediated apoptosis in MDCK cells in vitro, as well as restore body weight and ameliorate lung inflammation and apoptosis in H3N2-infected mice in vivo. Further investigation revealed that ebselen inhibits mitochondria-mediated apoptosis, thereby preventing H3N2-mediated apoptosis. In summary, this study suggests that ebselen has potential as anti-H3N2 influenza virus drug.

Concepts Keywords
Cardiovascular Apoptosis
Coronaviruses Ebselen
Decade H3N2
Free Mitochondrial
Mitochondria

Semantics

Type Source Name
drug DRUGBANK Ebselen
disease MESH influenza
pathway REACTOME Apoptosis
drug DRUGBANK Influenza A virus
drug DRUGBANK Selenium
disease IDO role
disease MESH cancer
disease MESH lung inflammation

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *